Nagasawa Takayuki 永沢崇幸

… Alternative Names

NAGASAWA Takayuki 永沢崇幸

Less

Researcher Number	10453309
Affiliation (Current)	2025: 岩手医科大学, 医学部, 特任講師
Affiliation (based on the past Project Information) *help	2023 – 2024: 岩手医科大学, 医学部, 特任講師 2019 – 2022: 岩手医科大学, 医学部, 助教 2013 – 2014: 岩手医科大学, 医学部, 助教 2008 – 2010: Iwate Medical University, 医学部, 助教
Review Section/Research Field	Principal Investigator Human pathology / Obstetrics and gynecology Except Principal Investigator Basic Section 56040:Obstetrics and gynecology-related
Keywords	Principal Investigator 遺伝子解析 / 腺管分離 / 腺管分離法 / 卵巣癌 / 子宮体癌 Except Principal Investigator 子宮体癌 / p53abn / MDSC / リンパ球 / 腫瘍微小環境 … More / マウスモデル / 局所免疫 / 漿液性癌 / 明細胞癌 / 卵巣癌 / バイオマーカー / NEFH / 卵巣明細胞癌 Less

Integrating precision medicine for p53abn endometrial cancer
- Principal Investigator
  
  馬場長
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Iwate Medical University
Development of tumor-host integrative therapies to overcome the refractory nature of uterine serous carcinoma
- Principal Investigator
  
  Baba Tsukasa
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Iwate Medical University
The NEFH pathway may be a novel therapeutic target for ovarian clear cell carcinoma
- Principal Investigator
  
  ITAMOCHI Hiroaki
- Project Period (FY)
  2019 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Iwate Medical University
Molecular pathological analysis of pure tumor glands using the crypt isolation method in epithelial ovarian carcinomasPrincipal Investigator
- Principal Investigator
  
  NAGASAWA Takayuki
- Project Period (FY)
  2013 – 2014
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Human pathology
- Research Institution
  Iwate Medical University
Molecular pathological analyses of single tumor gland using crypt isolation method in 25 endometrial carcinoma patientsPrincipal Investigator
- Principal Investigator
  
  NAGASAWA Takayuki
- Project Period (FY)
  2008 – 2010
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Iwate Medical University

All 2024 2023 2022 2021

All Journal Article

[Journal Article] A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification system2024
- Author(s)
  Chiba Yohei、Kagabu Masahiro、Osakabe Mitsumasa、Ito Rikako、Sato Sho、Takatori Eriko、Kaido Yoshitaka、Nagasawa Takayuki、Shoji Tadahiro、Yanagawa Naoki、Baba Tsukasa
- Journal Title
  
  Japanese Journal of Clinical Oncology
  
  Volume: 54 Issue: 4 Pages: 424-433
- DOI
  10.1093/jjco/hyad192
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K09548
[Journal Article] Efficacy and Safety of Platinum-based Chemotherapy with Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study.2023
- Author(s)
  Abe M, Shoji T, Chiba Y, Takatori E, Kaido Y, Nagasawa T, Kagabu M, Takahashi F, Aida T, Baba T.
- Journal Title
  
  Anticancer Res
  
  Volume: 43(3) Issue: 3 Pages: 1265-1272
- DOI
  10.21873/anticanres.16273
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K09548
[Journal Article] A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study)2023
- Author(s)
  Nagasawa Takayuki、Shoji Tadahiro、Takatori Eriko、Kaido Yoshitaka、Kagabu Masahiro、Shimizu Dai、Shigeto Tatsuhiko、Baba Tsukasa、Sugiyama Toru、Yokoyama Yoshihito
- Journal Title
  
  Cancers
  
  Volume: 15 Issue: 21 Pages: 5201-5201
- DOI
  10.3390/cancers15215201
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K09548
[Journal Article] Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study)2022
- Author(s)
  Takatori E, Nagasawa T, Kagabu M, Baba T, Shigeto T, Matsumura Y, Shimizu D, Terada Y, Seino M, Ohta T, Nagase S, Shigeta S, Tokunaga H, Shimada M, Kaiho-Sakuma M, Furukawa S, Soeda S, Watanabe T, Takahashi F, Yokoyama Y.
- Journal Title
  
  International Journal of Clinical Oncology
  
  Volume: 27 Issue: 12 Pages: 1874-1880
- DOI
  10.1007/s10147-022-02246-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K09531, KAKENHI-PROJECT-21K09548
[Journal Article] Efficacy and Safety of Platinum Rechallenge in Patients With Platinum-resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer: A Multicenter Retrospective Study.2022
- Author(s)
  Tatsuki S, Shoji T, Abe M, Tomabechi H, Takatori E, Kaido Y, Nagasawa T, Kagabu M, Aida T, Baba T.
- Journal Title
  
  Anticancer Res.
  
  Volume: 42(9) Issue: 9 Pages: 4603-4610
- DOI
  10.21873/anticanres.15964
- Data Source
  KAKENHI-PROJECT-21K09548
[Journal Article] Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study2021
- Author(s)
  Kagabu Masahiro、Nagasawa Takayuki、Tatsuki Shunsuke、Fukagawa Yasuko、Tomabechi Hidetoshi、Takatori Eriko、Kaido Yoshitaka、Shoji Tadahiro、Baba Tsukasa
- Journal Title
  
  Medicina
  
  Volume: 57 Issue: 6 Pages: 548-548
- DOI
  10.3390/medicina57060548
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K09548
[Journal Article] Novel therapeutic strategies for refractory ovarian cancers: Clear cell and mucinous carcinomas.2021
- Author(s)
  Shoji T, Tatsuki S, Abe M, Tomabechi H, Takatori E, Kaido Y, Nagasawa T, Kagabu M, Baba T, Itamochi H.
- Journal Title
  
  Cancers
  
  Volume: 13 Issue: 23 Pages: 6120-6120
- DOI
  10.3390/cancers13236120
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K09759

1. Baba Tsukasa (60508240)

# of Collaborated Projects: 3 results

# of Collaborated Products: 6 results
2. 利部正裕 (30382609)

# of Collaborated Projects: 3 results

# of Collaborated Products: 6 results
3. 大黒多希子 (30767249)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
4. 濱西潤三 (80378736)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
5. ITAMOCHI Hiroaki (20314601)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
6. 庄子忠宏 (00337148)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
7. 苫米地英俊 (10771363)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. 佐藤誠也 (30621007)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 深川安寿子 (30772511)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. 小島淳美 (60508753)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 菅井有 (20187628)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. 佐藤千絵 (70883726)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
13. 万代昌紀 (80283597)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. 山口建 (20378772)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. 佐藤翔 (90749863)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. 徳永英樹

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
17. 島田宗昭

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
18. 重田昌吾

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Nagasawa Takayuki 永沢 崇幸

NAGASAWA Takayuki 永沢 崇幸

Research Projects

Research Products

Co-Researchers

Integrating precision medicine for p53abn endometrial cancer

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of tumor-host integrative therapies to overcome the refractory nature of uterine serous carcinoma

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

The NEFH pathway may be a novel therapeutic target for ovarian clear cell carcinoma

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Molecular pathological analysis of pure tumor glands using the crypt isolation method in epithelial ovarian carcinomasPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Molecular pathological analyses of single tumor gland using crypt isolation method in 25 endometrial carcinoma patientsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification system2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Efficacy and Safety of Platinum-based Chemotherapy with Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study)2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study)2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Efficacy and Safety of Platinum Rechallenge in Patients With Platinum-resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer: A Multicenter Retrospective Study.2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Novel therapeutic strategies for refractory ovarian cancers: Clear cell and mucinous carcinomas.2021

Author(s)

Journal Title

DOI

Data Source

Nagasawa Takayuki 永沢崇幸

NAGASAWA Takayuki 永沢崇幸